How to manage the swelling of my son with HAE 1 at 18?
Patient's Query
Hello doctor,
My 18-year-old son has been experiencing terrifying swelling episodes, and after months of testing, we were finally given a diagnosis of hereditary angioedema type I.
His C1 esterase inhibitor level is critically low at six mg/dL (normal range: 21 to 39 mg/dL), and his C1-INH functional activity is only 12 percent of normal. The attacks involve massive facial swelling, especially of the lips and eyelids, lasting two to four days and occurring two to three times per month.
Last week, his larynx swelled during an episode, and we had to rush to the ER, where he was briefly intubated. It was absolutely terrifying. His complement C4 level is undetectable.
Please help.
Hello,
Welcome to icliniq.com.
I understand your concern.
Based on everything you have shared, your son’s diagnosis of hereditary angioedema (HAE) type I is clear. Given the critically low C1-INH levels (C1 esterase inhibitor), reduced functional activity, and undetectable C4, this is a classic and severe presentation.
Hereditary angioedema type I is a genetic condition in which the body produces too little C1 esterase inhibitor, a protein that regulates inflammation and swelling. Without it, bradykinin accumulates, leading to sudden, deep swelling episodes. These attacks can be life-threatening, especially when the airway or larynx is involved, as in your son’s recent episode.
Laryngeal swelling is a medical emergency. It can progress rapidly and cause suffocation. This type of swelling does not respond to standard allergy treatments (such as Epinephrine, steroids, or antihistamines) because it is not mediated by histamine.
Given the frequency and severity of his attacks, this is considered a case of severe HAE requiring both on-demand treatment and long-term prophylaxis.
The treatment strategy includes:
-
Emergency on-demand therapy: You must have medication at home for immediate use at the first sign of an attack:
-
C1-INH concentrates through IV (intravenous) infusion.
-
Icatibant through subcutaneous injection (blocks bradykinin).
-
Ecallantide is less common but blocks the bradykinin pathway.
Important: Train family members how to administer at home. He should never be without emergency medication.
-
Long-term prophylaxis: Given his attack frequency and severity, long-term prevention is essential:
-
Haegarda (subcutaneous C1-INH, two times a week).
-
Lanadelumab is subcutaneous and administered every two to four weeks; it is highly effective.
Older options like attenuated androgens (for example: Danazol) or antifibrinolytics (for example: Tranexamic acid) are rarely used in teens now due to side effects.
Additionally, please consider genetic counseling for family members as HAE is autosomal dominant, a medical bracelet stating HAE diagnosis and airway risk, and an emergency action plan shared with school, sports teams, etc.
I hope this has helped you.
Please feel free to reach out to me again if you have further queries.
Thank you.
Same symptoms don't mean you have the same problem. Consult a doctor now!
Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.